VEGFR1 single nucleotide polymorphisms associated with outcome in patients with metastatic renal cell carcinoma treated with sunitinib – a multicentric retrospective analysis-Reference-Cited by-同舟云学术

VEGFR1 single nucleotide polymorphisms associated with outcome in patients with metastatic renal cell carcinoma treated with sunitinib – a multicentric retrospective analysis

Published:2013-02-20 Issue:1 Volume:53 Page:103-112
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Beuselinck Benoit,Karadimou Alexandra,Lambrechts Diether,Claes Bart,Wolter Pascal,Couchy Gabrielle,Berkers Joost,van Poppel Hendrik,Paridaens Robert,Schöffski Patrick,Méjean Arnaud,Verkarre Virginie,Lerut Evelyne,Joly Florence,Lebret Thierry,Gravis Gwénaelle,Deplanque Gael,Descazeaud Aurélien,Leclercq Nathalie Rioux,Molinié Vincent,Patard Jean-Jacques,Teghom Corine,Elaidi Reza,Zucman-Rossi Jessica,Oudard Stéphane

Publisher

Informa UK Limited

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/0284186X.2013.770600

Reference21 articles.

1. Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma

2. Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma

3. Resistance to targeted therapy in renal-cell carcinoma

4. Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study

5. Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Renal Carcinoma and Angiogenesis: Therapeutic Target and Biomarkers of Response in Current Therapies;Cancers;2022-12-14

2. Genetic Polymorphisms in VEGFR Coding Genes (FLT1/KDR) on Ranibizumab Response in High Myopia and Choroidal Neovascularization Patients;Pharmaceutics;2022-07-26

3. Genome-Wide Meta-Analysis Identifies Variants in DSCAM and PDLIM3 That Correlate with Efficacy Outcomes in Metastatic Renal Cell Carcinoma Patients Treated with Sunitinib;Cancers;2022-06-08

4. The Anti-VEGF(R) Drug Discovery Legacy: Improving Attrition Rates by Breaking the Vicious Cycle of Angiogenesis in Cancer;Cancers;2021-07-08

5. Angiogenesis and Its Role in the Tumour Microenvironment: A Target for Cancer Therapy;Current Cancer Treatment;2020-06-24